Opioid Use Remained Common After Head and Neck Cancer Care
A new study found many patients continued taking prescription opioids months after completing radiation therapy.
Updated on Oct. 2, 2026 in Cancer
Live Poll
Should medical providers prioritize stricter opioid tapering protocols for cancer patients to reduce dependency risks?
Researchers at The Ohio State Comprehensive Cancer Center found that a large majority of head and neck cancer patients continued to use prescription opioids long after their radiation treatments concluded. The findings highlight the significant duration of pain management needs for this population.
Why it matters
Identifying these trends helps clinicians refine opioid stewardship programs, ensuring patients receive necessary pain relief while mitigating the risk of long-term dependency. This study underscores the importance of balancing aggressive symptom management with ongoing monitoring for cancer survivors.
In a retrospective cohort study of 789 patients with nonmetastatic head and neck cancer, researchers followed participants for a median of 46.7 months. While 95.1% were initially prescribed opioids, nearly half remained on the medications six months after radiation therapy.
The players
The Ohio State Comprehensive Cancer Center
An academic medical center that conducts oncology research and provides clinical care for complex cancer diagnoses.
The details
Researchers evaluated patients treated with definitive radiation doses according to National Comprehensive Cancer Network guidelines. The study identified factors such as prior opioid use, former smoking status, and referrals to palliative medicine as statistically significant predictors for continued use. Additionally, patients who were underweight or had earlier palliative care involvement faced a shorter time until their first opioid prescription was issued.
Timeline
October 2011 - December 2023: Patient diagnosis period for the study cohort.
3 months after radiation: Period where 552 patients continued prescription opioid use.
6 months after radiation: Period where 373 patients continued prescription opioid use.
October 1, 2026: Official study publication date.
Health Landscape
This research provides a deeper look at post-treatment recovery patterns for patients managed under National Comprehensive Cancer Network guidelines. It emphasizes the need for tailored stewardship as oncologists aim to balance pain relief with the prevention of long-term dependency.
If you or a loved one are undergoing radiation for head and neck cancer, it is worth discussing a long-term pain management plan with your oncology team. Tracking your medication usage and discussing any persistent pain concerns can help your doctor adjust your care strategy safely.
The takeaway
Chronic pain management is a frequent requirement for survivors of head and neck cancer. Patients should speak with their physician about regular medication reviews to assess if pain management needs are being addressed effectively as recovery progresses.
Further reading
For more on evolving treatment standards, read about the latest developments in Cancer.
Live Poll
Should medical providers prioritize stricter opioid tapering protocols for cancer patients to reduce dependency risks?
